Literature DB >> 30335680

Increased pain sensitivity and decreased opioid analgesia in T-cell-deficient mice and implications for sex differences.

Sarah F Rosen1, Boram Ham, Michael Haichin, Ilana C Walters, Sarasa Tohyama, Susana G Sotocinal, Jeffrey S Mogil.   

Abstract

The processing of pain in the central nervous system is now known to have an important immune component, including T cells of the adaptive immune system. T cells have been shown to release endogenous opioids, and although it is well known that opioids have effects on T-cell populations, very little attention has been given to the converse: how T cells may affect opioid regulation. We find here that, in addition to displaying significantly increased baseline pain sensitivity across various pain modalities, T-cell-deficient mice (CD-1 nude, Rag1 null mutant, and Cd4 null mutant) exhibit pronounced deficiencies in morphine inhibition of thermal or inflammatory pain. Nude mice are also deficient in endogenous opioid-mediated analgesia, exhibiting no stress-induced analgesia from restraint. The relevant T-cell subpopulation seems to be CD4 T cells because adoptive transfer of them but not CD8 cells into nude mice rescues both the pain and morphine analgesia phenotypes. As previously reported, we also observe a sex difference in CD-1 mice, with females requiring 2- to 3-fold more morphine than males to produce equal analgesia. Nude mice display no sex differences in morphine analgesia, and the sex difference is restored in nude mice of either sex receiving CD4 T cells from CD-1 donor male or female mice. These results suggest that CD4 T cells play an as yet unappreciated role in opioid analgesia and may be a driver of sex differences therein.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30335680     DOI: 10.1097/j.pain.0000000000001420

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  30 in total

1.  Recent advances toward understanding the mysteries of the acute to chronic pain transition.

Authors:  Theodore J Price; Pradipta R Ray
Journal:  Curr Opin Physiol       Date:  2019-06-04

Review 2.  Qualitative sex differences in pain processing: emerging evidence of a biased literature.

Authors:  Jeffrey S Mogil
Journal:  Nat Rev Neurosci       Date:  2020-05-21       Impact factor: 34.870

3.  Neuroendocrine Mechanisms Governing Sex Differences in Hyperalgesic Priming Involve Prolactin Receptor Sensory Neuron Signaling.

Authors:  Candler Paige; Priscilla A Barba-Escobedo; Jennifer Mecklenburg; Mayur Patil; Vincent Goffin; David R Grattan; Gregory Dussor; Armen N Akopian; Theodore J Price
Journal:  J Neurosci       Date:  2020-08-12       Impact factor: 6.167

4.  A Review of Strain and Sex Differences in Response to Pain and Analgesia in Mice.

Authors:  Jennifer C Smith
Journal:  Comp Med       Date:  2019-12-10       Impact factor: 0.982

5.  Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents.

Authors:  Caroline M Kopruszinski; Juliana Swiokla; Yeon Sun Lee; Edita Navratilova; Laurie VanderVeen; Miao Yang; Yi Liu; Takahiro Miyazaki; William K Schmidt; Jonathan Zalevsky; Frank Porreca
Journal:  Cell Mol Neurobiol       Date:  2020-02-27       Impact factor: 5.046

6.  Diversity of Receptor Expression in Central and Peripheral Mouse Neurons Estimated from Single Cell RNA Sequencing.

Authors:  Andi Wangzhou; Candler Paige; Pradipta R Ray; Gregory Dussor; Theodore J Price
Journal:  Neuroscience       Date:  2021-03-26       Impact factor: 3.590

7.  Sex Differences in Nociceptor Translatomes Contribute to Divergent Prostaglandin Signaling in Male and Female Mice.

Authors:  Diana Tavares-Ferreira; Pradipta R Ray; Ishwarya Sankaranarayanan; Galo L Mejia; Andi Wangzhou; Stephanie Shiers; Ruta Uttarkar; Salim Megat; Paulino Barragan-Iglesias; Gregory Dussor; Armen N Akopian; Theodore J Price
Journal:  Biol Psychiatry       Date:  2020-10-05       Impact factor: 13.382

8.  Sexually dimorphic neuroimmune response to chronic opioid treatment and withdrawal.

Authors:  Mohit Kumar; Jennifer R Rainville; Kori Williams; Joshua A Lile; Georgia E Hodes; Fair M Vassoler; Jill R Turner
Journal:  Neuropharmacology       Date:  2021-01-22       Impact factor: 5.250

9.  A ligand-receptor interactome platform for discovery of pain mechanisms and therapeutic targets.

Authors:  Andi Wangzhou; Candler Paige; Sanjay V Neerukonda; Dhananjay K Naik; Moeno Kume; Eric T David; Gregory Dussor; Pradipta R Ray; Theodore J Price
Journal:  Sci Signal       Date:  2021-03-16       Impact factor: 8.192

Review 10.  Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain?

Authors:  Kufreobong E Inyang; Joseph K Folger; Geoffroy Laumet
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.